Though NUP98-RARG transformed murine HSPCs was sensitive to ATRA treatment ex vivo, all of NUP98-RARG-positive APL patients showed resistance to ATRA in clinic, and chemotherapy was required for their CR achievement. The gene discussed is RARG; the disease is acute promyelocytic leukemia.